CVS Beats Q3 Estimates but Shares Slip

Published on: 06 Nov, 2017

CVS Health Corp. (NYSE:CVS) reported its third quarter earnings and beat analysts’ estimates, but shares fell by over 3 percent early shortly after open on Monday.

For the third quarter, CVS reported revenue of $46.18 billion, increasing 3.5 percent year over year, and beating Thomson Reuters analysts’ estimates of $46.17 billion. The company reported an EPS of $1.50, decreasing 9 percent year over year, but beating Thomson Reuters analysts’ estimates of $1.48.

Pharmacy services segment revenue increased 8.1 percent to $32.9 billion, which majority of the net revenue comes from. Retail/LTC segment revenue decreased 2.7 percent to $19.6 billion, the decrease was driven mainly to decrease in same store sales and increase in dispensing rates as well as reimbursement pressure.

Pharmacy same store sales decreased 3.4 percent, while front store same store sales declined 2.8 percent.

Net income for the company has now fallen 16.6 percent year over year from $1.54 billion to $1.28 billion.

CVS opened up 56 new locations, while closing five and relocating five. As of the end of the third quarter, it had 9,751 operating location. For the nine months ending in September, the company closed down 68 location and reiterated that it will close down another 70 stores by the end of the year, expecting a total cumulative charge of $220 million.

CVS reportedly bidded on acquiring Aetna for $66 billion in October, according to sources familiar with the matter. The merger of the two companies would diversify CVS portfolio even more by adding on health related insurance plans.

The report came shortly after Amazon had announced that it received approval for wholesale pharmacy licenses in some states.

After CVS had released its earnings, it announced that it will deliver prescription drugs straight to customers within the same day or the next day starting in early 2018. Same-day delivery will expand to Miami, Boston, Philadelphia, Washington, DC and San Francisco in 2018.

CVS has now lowered its full year earnings outlook. The company lowered its adjusted EPS outlook from $5.83 to $5.93 to $5.87 to $5.91. For the fourth quarter, the company expects to deliver an adjusted EPS of $1.88 to $1.92. The changes include the impact of the Hurricane.

Ratings

Ratings
  • 374Views
  • 0Comments

Recommend to Friends

  • facebook
  • Twitter
  • google plus
  • pinterest
  • Digg
  • stumbleupon
  • Reddit
  • linkedin

Danny Abramov

Email: danny@financialinsiders.com

@Newsletter

Sign Up for Weekly Updates

Related Posts

26 Jun, 2017 558
03 Jul, 2017 519
14 Jul, 2017 724
30 Aug, 2017 5850

Comments

There is no comment on this article